Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1921-1940 of 2,731 trials

Centralized Reminder Recall - Flu RCT2

NCT03294473

This study is related to a previous study, Clinicaltrials.gov ID: NCT02924467. There are some modifications in relation to the intervention arms as well as the use of a different cohort, thereby justifying the second submission to Clinicaltrials.gov. This trial is taking place in New York State, through partnership with the New York State Health Department (excluding New York City), and Colorado. Each state will have it's own Clinicaltrial.gov submission -- this was decided as some of the intervention components are different enough that separate registrations were warranted. Despite U.S. guidelines for influenza vaccination of all children starting at 6 months, only about half of children are vaccinated annually leading to substantial influenza disease in children and spread of disease to adults. A major barrier is that families are not reminded about the need for their children to receive influenza vaccination. The investigators will evaluate the impact of patient reminder/recall (R/R) performed by state immunization information systems to improve influenza vaccination rates by using 4 clinical trials (2 per state) in two different states. The investigators will assess effectiveness and cost-effectiveness of 1) autodialer R/R 2) text messages R/R 3) mailed postcard R/R as compared to 4) standard of care control (no R/R).

Influenza, HumanOrthomyxoviridae InfectionsRNA Virus Infections+5 more

University of California, Los Angeles70,190 participantsStarted Oct 2017

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

NCT01544491

The purpose of this study is to determine if everolimus combined with reduced exposure CNI (TAC) is efficacious and safe and will support corticosteroid elimination compared to a standard exposure CNI (TAC) + MMF + steroid regimen after paediatric kidney transplantation. An additional purpose of the study is to assess the effect of the combination of EVR and reduced exposure CNI (TAC) on renal function. This study is part of the requirements of the Paediatric Investigational Plan approved by Paediatric Committee at the European Medicines Agency (PDCO/EMA) on September 10, 2010, and is intended to support the indication of everolimus in the prevention of acute rejection in paediatric recipients of a renal transplant.

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Novartis Pharmaceuticals106 participantsStarted Aug 2012

Los Angeles, California, United States • Ann Arbor, Michigan, United States • St Louis, Missouri, United States +28 more locations

Centralized Reminder Recall - Flu RCT2

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Rheumatoid Arthritis Trials in Other Cities

12 Month Open Extension of TNS for ADHD.

The Chimerix CMX001 Registry

Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis

Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

A Study of LY2951742 in Healthy Japanese and Caucasian Participants

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Contact Lenses With New UV-blocker Manufactured With Different Techniques

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

MEmbranous Nephropathy Trial Of Rituximab

Other Conditions in Los Angeles